Cargando…
Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension
Pulmonary hypertension (PH) is recognized to be associated with a number of comorbid conditions. Based on these associations, PH is classified into 5 groups, considering common pathophysiologic drivers of disease, histopathologic features, clinical manifestations and course, and response to PH thera...
Autores principales: | Al-Qadi, Mazen, LeVarge, Barbara, Ford, H. James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026868/ https://www.ncbi.nlm.nih.gov/pubmed/33842491 http://dx.doi.org/10.3389/fmed.2020.616720 |
Ejemplares similares
-
Prostanoid therapies in the management of pulmonary arterial hypertension
por: LeVarge, Barbara L
Publicado: (2015) -
Identification of iron and heme utilization genes in Aeromonas and their role in the colonization of the leech digestive tract
por: Maltz, Michele, et al.
Publicado: (2015) -
Occult catheter rupture causing episodic symptoms in a patient treated with epoprostenol
por: LeVarge, Barbara L., et al.
Publicado: (2017) -
Pathogenesis of pulmonary hypertension caused by left heart disease
por: Xiao, Mingzhu, et al.
Publicado: (2023) -
Novel TNIP2 and TRAF2 Variants Are Implicated in the Pathogenesis of Pulmonary Arterial Hypertension
por: Pienkos, Shaun, et al.
Publicado: (2021)